Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Lipodystrophy Indication Strategy Report 2026: LMNA, Trials and Deals
21 July 2026
Lipodystrophy indication strategy report covering epidemiology, LMNA biology, active trials, competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
8 min read
Maturity-onset diabetes of the young Indication Strategy Report 2026: glucokinase, Trials and Deals
21 July 2026
Maturity-onset diabetes of the young indication strategy report covering epidemiology, glucokinase biology, active trials, competition and deal signals using...
Latest Hotspot
8 min read
Monogenic diabetes Indication Strategy Report 2026: glucokinase, Trials and Whitespace
21 July 2026
Monogenic diabetes indication strategy report covering epidemiology, glucokinase biology, active trials, competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
8 min read
Prediabetes Indication Strategy Report 2026: GLP-1R, Trials and Deals
21 July 2026
Prediabetes indication strategy report covering epidemiology, GLP-1R biology, active trials, competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
8 min read
Pediatric obesity Indication Strategy Report 2026: MC4R, Trials and Deals
21 July 2026
Pediatric obesity indication strategy report covering epidemiology, MC4R biology, active trials, competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
8 min read
Bronchiolitis obliterans syndrome Indication Strategy Report 2026: JAK1, Trials and Deals
21 July 2026
Bronchiolitis obliterans syndrome indication strategy report covering epidemiology, JAK1 biology, active trials, competition and deal signals using PatSnap MCP...
Latest Hotspot
8 min read
Progressive pulmonary fibrosis Indication Strategy Report 2026: TGF-β1, Trials and Deals
21 July 2026
Progressive pulmonary fibrosis indication strategy report covering epidemiology, TGF-β1 biology, active trials, competition and deal signals using PatSnap MCP...
Latest Hotspot
8 min read
Hypersensitivity pneumonitis Indication Strategy Report 2026: TNF, Trials and Deals
21 July 2026
Hypersensitivity pneumonitis indication strategy report covering epidemiology, TNF biology, active trials, competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
8 min read
Bronchopulmonary dysplasia Indication Strategy Report 2026: VEGF-A, Trials and Deals
21 July 2026
Bronchopulmonary dysplasia indication strategy report covering epidemiology, VEGF-A biology, active trials, competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
8 min read
Acute respiratory distress syndrome Indication Strategy Report 2026: IL-6R, Trials and Deals
21 July 2026
Acute respiratory distress syndrome indication strategy report covering epidemiology, IL-6R biology, active trials, competition and deal signals using PatSnap...
Latest Hotspot
8 min read
Chronic obstructive pulmonary disease Indication Strategy Report 2026: PDE4B, Trials and Deals
21 July 2026
Chronic obstructive pulmonary disease indication strategy report covering epidemiology, PDE4B biology, active trials, competition and deal signals using PatSnap...
Latest Hotspot
8 min read
Bronchiectasis Indication Strategy Report 2026: DPP-1, Trials and Deals
21 July 2026
Bronchiectasis indication strategy report covering epidemiology, DPP-1 biology, active trials, competition and deal signals using PatSnap MCP evidence.